- Home
- GDEV vs LFCR Comparison
GDEV vs LFCR Comparison
Compare GDEV & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDEV
- LFCR
- Stock Information
- Founded
- GDEV 2009
- LFCR 1986
- Country
- GDEV Cyprus
- LFCR United States
- Employees
- GDEV N/A
- LFCR N/A
- Industry
- GDEV EDP Services
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- GDEV Technology
- LFCR Health Care
- Exchange
- GDEV Nasdaq
- LFCR Nasdaq
- Market Cap
- GDEV 266.7M
- LFCR 288.0M
- IPO Year
- GDEV N/A
- LFCR N/A
- Fundamental
- Price
- GDEV $35.43
- LFCR $6.86
- Analyst Decision
- GDEV
- LFCR Buy
- Analyst Count
- GDEV 0
- LFCR 4
- Target Price
- GDEV N/A
- LFCR $8.00
- AVG Volume (30 Days)
- GDEV 21.4K
- LFCR 211.7K
- Earning Date
- GDEV 11-13-2025
- LFCR 10-03-2025
- Dividend Yield
- GDEV 9.14%
- LFCR N/A
- EPS Growth
- GDEV 12.96
- LFCR N/A
- EPS
- GDEV 2.56
- LFCR N/A
- Revenue
- GDEV $425,112,000.00
- LFCR $128,867,000.00
- Revenue This Year
- GDEV N/A
- LFCR $4.71
- Revenue Next Year
- GDEV $1.39
- LFCR $10.98
- P/E Ratio
- GDEV $14.14
- LFCR N/A
- Revenue Growth
- GDEV N/A
- LFCR 0.47
- 52 Week Low
- GDEV $8.60
- LFCR $4.33
- 52 Week High
- GDEV $42.76
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- GDEV 72.19
- LFCR 40.03
- Support Level
- GDEV $27.00
- LFCR $7.00
- Resistance Level
- GDEV $40.97
- LFCR $7.46
- Average True Range (ATR)
- GDEV 6.14
- LFCR 0.42
- MACD
- GDEV 1.42
- LFCR -0.07
- Stochastic Oscillator
- GDEV 76.58
- LFCR 12.59
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.